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Introduction
One of the biggest challenge for the clinician is when the
patient still persists with complaints of orofacial pain, even
with the adoption of well known and appropriate treatment.
One of the reasons for this fact can be the misdiagnosis,
very often in the field of orofacial pain, since the trigeminal
system is frequently influenced by a diversity of different
neural inputs. The presence of systemic diseases affecting
the masticatory apparatus is also part of this scenario. One
of this is a rare condition: auriculotemporal neuralgia (AN)
[1].
The aim of the present study was to report a case of
refractory facial pain after successful temporomandibular
disorder (TMD) management, attributed to AN.
Case report
A 43-year-old Caucasian female patient presented for
treatment of facial pain, with complaint of severe episodic
pain in right face, ear and neck, first appeared 12 years ago,
worsening in the last 3 months, with crisis of sharp and
severe pain. The patient was previously diagnosed with
sleep bruxism, depression and insomnia.
Physical examination revealed moderate pain upon
palpation of right temporomandibular joint (TMJ), super-
ficial masseter, occipital and sternocleidomastoid muscles.
A trigger point was found in right medium masseter muscle
referring pain to the ipsilateral ear and TMJ. The maximum
mouth opening (MMO) with pain was 39 mm and no other
significant signs were detected.
Masticatory myofascial pain and cervicalgia were the
initial diagnosis and treatment consisted of advisement of
the condition, counseling to avoid clenching her teeth
during the day, hot packets and the nocturnal use of an
occlusal stabilization splint in the upper jaw. The patient
was also referred to a psychologist, physician and physical
therapist for management of depression, insomnia and
cervicalgia.
After 3 months, the patient reported a significant
improvement, with no pain upon muscle palpation or
function, and the MMO was 46 mm. However, she com-
plained of a paroxysmal, short-duration pain below the
right TMJ and in the temporal region, triggered by MMO
and mastication. Intraoral and radiographic exams were
unremarkable. Extra oral physical examination revealed
that the palpation of the right auriculotemporal nerve
region elicited a sharp pain familiar to the patient, which
extended from below TMJ to the temporal region.
The hypotheses diagnosis was AN. The auriculotem-
poral nerve was then blocked with 0.5 ml 2 % lidocaine
and 0.5 ml of a suspension containing dexamethasone
disodium sulfate (2 mg/ml) and dexamethasone acetate
(8 mg/ml) as follows: the needle is inserted below the TMJ,
in the posterior margin of the head of the mandible
immediately in front of the tragus, to a depth of 1–1.2 cm,
at a horizontal 458 angle in the direction of the nose, with
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care taken to first perform aspiration in order to avoid
intravascular injection [1].
There was full improvement of painful symptoms after a
single blockade, with no recurrence after a 12-month fol-
low-up.
Discussion
The diagnosis of orofacial pain is a challenge for dentists
and physicians and becomes even more complicated when
the signs and symptoms of the patient are due to rare eti-
ologies such AN.
Auriculotemporal neuralgia is characterized by crises of
strictly unilateral lancinating pain that may be perceived in
the temporal region, TMJ, and in the parotid, auricular and
retro-orbital region [2]. In the differential diagnosis, other
diseases that might provoke similar AN symptoms must be
excluded, such as cervicalgia, TMD, migraine, continuous
hemicrania, otitis, trigeminal neuralgia, atypical facial
pain, ‘‘red ear syndrome’’, affection of the parotid gland,
temporal arteritis and odontalgia. In this case, an interdis-
ciplinary treatment planning between different health pro-
fessions was needed for the pain control. Moreover, a
conservative, reversible, low-cost and low-tech approach
was sufficient for controlling the TMD pain as has been
shown previously [3].
According to the International Classification of Head-
aches, damage to and imprisonment of the peripheral
branch of the trigeminal nerve may trigger referred pain in
the area innervated by the affected branch [4]. Nerve
entrapments in the infratemporal fossa with a spastic con-
dition of the lateral pterygoid muscle may be causally
related to compression of auriculotemporal nerve that leads
to numbness, pain or both, in the respective areas of nerve
distribution [5].
The main clinical characteristics of AN are moderate to
severe pain, associated with exacerbations, perceived as
stabbing pain. The pain may worsen or be triggered by
pressure on the periauricular region at the level of the
tragus [1].
In this case, the pain could be triggered with chewing.
The lateral pterygoid muscle is activated in mastication. Its
superior head contracts during jaw closing while the infe-
rior head contracts during protraction, opening and shifting
of the jaw to one side. If either or both of its heads are
actively recruited during mandibular closure, this muscle
could present an tonic contraction [6] which could lead to
stiffness and pain, symptoms commonly found in TMD
patients. It is interesting to note that in this case, the
relationship between the initial painful symptoms and the
final diagnosis of AN is not clear. One hypothesis would be
that the patient already had both AN and TMD but, at that
moment, the TMD symptoms were possibly more
noticeable.
Auriculotemporal neuralgia occurs at a frequency of
0.4 % at a tertiary headache outpatient clinic [1]. However,
this frequency may be even higher in outpatient orofacial
pain due to the possible involvement of lateral pterygoid
muscle in the etiology of auriculotemporal nerve entrap-
ment. It is important to notice that there is no evidence that
AN was the cause or consequence of TMD in this case. So
far, no data on this were published.
The blockade of the auriculotemporal nerve in the infra-
temporal fossa is diagnostic and therapeutic. As in others
peripheral nerve blocks, it can be achieved with a solution of
lidocaine or bupivacaine, with or without a steroid [7].
It is interesting to note that pain relief exceeds the effect
of local anesthetic solution in blockades performed not
only in AN but also in other peripheral nerve blocks. The
use of lidocaine as an anesthetic in these cases appears to
promote reversible inhibition of sodium channels, inhibit-
ing nerve conduction in sensory fibers and thus providing
temporary analgesia [8].
It has been suggested that chronic changes in nocicep-
tive processing and neuroplasticity may occur in blockades
of the occipital nerves, which also has prolonged effect [9].
However, the mechanisms involved in the prolonged effect
of peripheral blockade have not been fully elucidated.
Although the effects of locally applied corticosteroids
have not been determined, it has been suggested that this
treatment may suppress the afferent ectopic firings at the
site of nerve injury by an action of C fibers (nociceptive),
reducing the release of neuropeptides [10]. The use of
prolonged-action corticosteroids in combination with local
anesthetics may cause a sufficient prolongation of the time
of analgesia to inhibit already established secondary sen-
sitizations, with consequent permanent or greatly pro-
longed analgesia, as was the case for the present patient.
The present clinical case report suggests that AN may be
considered as source of persistent pain in TMD patients
and, therefore should be considered in the differential
diagnosis or as a comorbid condition, as in the case
presented.
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